David Maris
expertMale0.0Global Dominance: 0.00%
David Maris is a managing partner at Phalanx Investment Partners, with a background in financial analysis of the drug industry, providing insights into how policy changes like tariffs can affect drug pricing and market dynamics.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
David Maris, a managing partner at Phalanx Investment Partners, discussed the challenges drug companies face in passing along price increases.
Trump drug tariffs would drive up prices, worsen shortages before any boost to US manufacturing, experts warnCNN·
United States· 2025-04-09
United States· 2025-04-09
